The Recall Desk

Hazard

Cross Contamination recalls

439 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
439
Critical
6
Severe
158
Most recent
2026-10-07

Of the 439 cross contamination recalls we have scored against our rubric, 6 (1%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 158 (36%) are Severe.

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all cross contamination recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

376–400 of 439

  • HighFDA (Drugs)·D-732-2015·2015-04-29

    Attix Pharmaceuticals Recalls Indocyanine Green Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Indocyanine Green active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Indocyanine Green active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-935-2015·2015-04-29

    Tolvaptan API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling Tolvaptan active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Tolvaptan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-839-2015·2015-04-29

    Attix Pharmaceuticals Recalls Phenolphthalein Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Phenolphthalein active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Phenolphthalein active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-650-2015·2015-04-29

    Attix Pharmaceuticals Recalls Epinephrine Ingredient Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling epinephrine active pharmaceutical ingredient distributed to compounding pharmacies and research organizations due to potential penicillin cross-contamination.

    Product
    Epinephrine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-570-2015·2015-04-29

    Attix Pharmaceuticals Recalls Celecoxib API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of Celecoxib active pharmaceutical ingredient repackaged between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Celecoxib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-660-2015·2015-04-29

    Attix Pharmaceuticals Recalls Ethambutol HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Ethambutol HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Ethambutol HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-648-2015·2015-04-29

    Attix Pharmaceuticals Recalls Enalapril Maleate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Enalapril Maleate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Enalapril Maleate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-884-2015·2015-04-29

    Attix Pharmaceuticals Recalls Roflumilast API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Roflumilast active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Roflumilast active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-630-2015·2015-04-29

    Attix Pharmaceuticals Recalls Digoxin Ingredient Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Digoxin active pharmaceutical ingredient repackaged between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Digoxin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-615-2015·2015-04-29

    Attix Pharmaceuticals Recalls Daptomycin API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Daptomycin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Daptomycin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-894-2015·2015-04-29

    Silver Sulfadiazine Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling Silver Sulfadiazine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Silver Sulfadiazine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-780-2015·2015-04-29

    Attix Pharmaceuticals Recalls Metaxalone API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Metaxalone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Metaxalone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-528-2015·2015-04-29

    Atovaquone API Recalled for Potential Penicillin Cross-Contamination

    Attix Pharmaceuticals is recalling Atovaquone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Atovaquone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-618-2015·2015-04-29

    Attix Pharmaceuticals Recalls Demecarium Bromide Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Demecarium Bromide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Demecarium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-688-2015·2015-04-29

    Flurbiprofen API Recalled for Potential Penicillin Cross-Contamination

    Attix Pharmaceuticals is recalling flurbiprofen active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Flurbiprofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-666-2015·2015-04-29

    Attix Pharmaceuticals Recalls Etoposide Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Etoposide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Etoposide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-561-2015·2015-04-29

    Attix Pharmaceuticals Recalls Carbimazole Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Carbimazole active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Carbimazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-769-2015·2015-04-29

    Attix Pharmaceuticals Recalls Loratadine API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Loratadine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Loratadine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-778-2015·2015-04-29

    Attix Pharmaceuticals Recalls Memantine HCl Due to Penicillin Cross Contamination Risk

    Attix Pharmaceuticals is recalling Memantine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Memantine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-581-2015·2015-04-29

    Attix Pharmaceuticals Recalls Chlorpromazine HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Chlorpromazine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Chlorpromazine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-609-2015·2015-04-29

    Attix Pharmaceuticals Recalls Dacarbazine Due to Penicillin Cross Contamination Risk

    Attix Pharmaceuticals is recalling Dacarbazine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Dacarbazine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-938-2015·2015-04-29

    Attix Pharmaceuticals Recalls Tranexamic Acid Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Tranexamic Acid active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Tranexamic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-703-2015·2015-04-29

    Attix Pharmaceuticals Recalls Heparin Sodium Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Heparin Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Heparin Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-608-2015·2015-04-29

    D-Cycloserine API Recalled for Potential Penicillin Cross-Contamination

    Attix Pharmaceuticals is recalling D-Cycloserine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    D-Cycloserine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-550-2015·2015-04-29

    Attix Pharmaceuticals Recalls Budesonide API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling budesonide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Budesonide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide